Stay updated on Galegenimab in Geographic Atrophy AMD: Clinical Trial

Sign up to get notified when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galegenimab in Geographic Atrophy AMD: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:06:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    An NIH-wide notice about terminology changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study page itself continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-21T00:07:52.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:50.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual study record content and navigation. This indicates restricted access to the NCT03972709 page on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-23T00:07:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.6.6 to v3.7.0, indicating a recent maintenance/update to the page's version.
    Difference
    0.0%
    Check dated 2026-09-16T00:43:10.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new revision number (v3.6.6) has been published, replacing v3.6.5. This indicates a small update to the page’s versioning without any described substantive changes.
    Difference
    0.0%
    Check dated 2026-09-01T20:12:50.000Z thumbnail image

Stay in the know with updates to Galegenimab in Geographic Atrophy AMD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galegenimab in Geographic Atrophy AMD: Clinical Trial page.